Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 170
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 118
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 72
Navigating the pitfalls of mapping DNA and RNA modifications
Yimeng Kong, Edward A. Mead, Gang Fang
Nature Reviews Genetics (2023) Vol. 24, Iss. 6, pp. 363-381
Closed Access | Times Cited: 36
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
Shimeng Zhou, Junlan Liu, Andi Wan, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 19
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 12
Genetic and epigenetic defects of the RNA modification machinery in cancer
Ines Oršolić, Arnaud Carrier, Manel Esteller
Trends in Genetics (2022) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 63
NSUN2‐mediated m5C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression
Sipeng Zuo, Lin Li, Xuyang Wen, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 23
NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression
Guanzhao Zong, Xing Wang, Xingya Guo, et al.
Experimental Cell Research (2023) Vol. 428, Iss. 2, pp. 113620-113620
Closed Access | Times Cited: 22
Role of histone methylation in skin cancers: Histone methylation–modifying enzymes as a new class of targets for skin cancer treatment
Natasha Christabella Sutopo, Ji Hye Kim, Jae Youl Cho
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188865-188865
Closed Access | Times Cited: 21
Research progress of N1-methyladenosine RNA modification in cancer
Yafeng Liu, Shujun Zhang, Xiaohui Gao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
Chen Xue, Xinyu Gu, Qingmiao Shi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysis
Ruo Qi Li, Lei Yan, Ling Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Codon-optimization in gene therapy: promises, prospects and challenges
Anastasiia Iu. Paremskaia, Anna A. Kogan, А. А. Мурашкина, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 9
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues
Ana M. Añazco-Guenkova, Borja Miguel‐López, Óscar Monteagudo-García, et al.
NAR Cancer (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 7
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 6
Tumor microenvironment activated mussel-inspired hollow mesoporous nanotheranostic for enhanced synergistic photodynamic/chemodynamic therapy
Hao Yan, Moon-Sun Jang, Changling Liu, et al.
Journal of Colloid and Interface Science (2024) Vol. 665, pp. 188-203
Closed Access | Times Cited: 6
RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
Huanxiang Chen, Hongyang Liu, Chenxing Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 6
Epigenetics in the modern era of crop improvements
Yan Xue, Xiaofeng Cao, Xiangsong Chen, et al.
Science China Life Sciences (2025)
Open Access
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
Shiheng Jia, Xue Yu, Na Deng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
Muhammad Khan, Mei-Ling Ai, Kunpeng Du, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top